Table 4. SNP (c.309 T>G) in the MDM2 gene and allele frequencies in primary lung cancer patients.
Number of patients (%) | Allele frequency (309G) | ||||
Total | T/T | T/G | G/G | ||
Adenocarcinoma | 306 | 67 (21.9) | 137 (44.8) | 102 (33.3) | 55.7% |
Squamous cell carcinoma | 40 | 9 (22.5) | 18 (45.0) | 13 (32.5) | 55.0% |
Others | 37 | 6 (16.2) | 15 (44.4) | 16 (42.1) | 63.2% |